Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WAJIHA A QAMAR

Allopathic & Osteopathic Physicians Family Medicine

NPI
1346529336
CMS profile
15967
Location
HOUSTON, TX

General Payments · PY2018–2024

$3,166.63

  • Reported across 218 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$787.60

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $787.60 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
MIMEDX Group, Inc. $315.25 9
Novo Nordisk AS $194.23 7
GlaxoSmithKline, LLC. $143.35 13
Acerta Pharma LLC $33.27 2
Smith & Nephew, Inc. $23.71 1
TACTILE SYSTEMS TECHNOLOGY INC $22.85 1
Urgo Medical North America, LLC $19.52 1
Lilly USA, LLC $18.12 1
DEXCOM, INC. $17.30 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $491.81 37
PY2019 $503.94 36
PY2020 $394.85 29
PY2021 $269.77 24
PY2022 $567.49 48
PY2023 $151.17 8
PY2024 $787.60 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.72 08/28/2024 Food and Beverage Undisputed 01/23/2026 1104583224 CMS
AstraZeneca Pharmaceuticals LP $14.55 10/03/2024 Food and Beverage Undisputed 01/23/2026 1105330037 CMS
Dexcom, Inc. $17.30 09/05/2024 Food and Beverage Undisputed 01/23/2026 1153343429 CMS
GlaxoSmithKline, LLC. $14.93 01/04/2024 Food and Beverage Undisputed 01/23/2026 1115838569 CMS
GlaxoSmithKline, LLC. $6.91 01/09/2024 Food and Beverage Undisputed 01/23/2026 1116138460 CMS
GlaxoSmithKline, LLC. $13.38 02/16/2024 Food and Beverage Undisputed 01/23/2026 1115958724 CMS
GlaxoSmithKline, LLC. $13.01 04/26/2024 Food and Beverage Undisputed 01/23/2026 1116269274 CMS
GlaxoSmithKline, LLC. $8.74 05/02/2024 Food and Beverage Undisputed 01/23/2026 1116659955 CMS
GlaxoSmithKline, LLC. $10.79 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116443753 CMS
GlaxoSmithKline, LLC. $12.95 06/04/2024 Food and Beverage Undisputed 01/23/2026 1116272096 CMS
GlaxoSmithKline, LLC. $3.75 06/27/2024 Food and Beverage Undisputed 01/23/2026 1116232355 CMS
GlaxoSmithKline, LLC. $1.96 06/28/2024 Food and Beverage Undisputed 01/23/2026 1116280161 CMS
GlaxoSmithKline, LLC. $13.94 07/29/2024 Food and Beverage Undisputed 01/23/2026 1116572793 CMS
GlaxoSmithKline, LLC. $7.84 08/29/2024 Food and Beverage Undisputed 01/23/2026 1116687297 CMS
GlaxoSmithKline, LLC. $18.11 10/15/2024 Food and Beverage Undisputed 01/23/2026 1116394250 CMS
GlaxoSmithKline, LLC. $17.04 11/20/2024 Food and Beverage Undisputed 01/23/2026 1116475562 CMS
Lilly USA, LLC $18.12 02/28/2024 Food and Beverage Undisputed 01/23/2026 1135441119 CMS
MIMEDX Group, Inc. $22.72 04/22/2024 Food and Beverage Undisputed 01/23/2026 1140267503 CMS
MIMEDX Group, Inc. $90.86 05/08/2024 Food and Beverage Undisputed 01/23/2026 1140267505 CMS
MIMEDX Group, Inc. $6.77 07/30/2024 Food and Beverage Undisputed 01/23/2026 1140267507 CMS
MIMEDX Group, Inc. $2.80 07/30/2024 Food and Beverage Undisputed 01/23/2026 1140267509 CMS
MIMEDX Group, Inc. $132.81 08/08/2024 Food and Beverage Undisputed 01/23/2026 1140267511 CMS
MIMEDX Group, Inc. $6.14 08/27/2024 Food and Beverage Undisputed 01/23/2026 1140267513 CMS
MIMEDX Group, Inc. $14.22 10/30/2024 Food and Beverage Undisputed 01/23/2026 1140267515 CMS
MIMEDX Group, Inc. $16.07 12/05/2024 Food and Beverage Undisputed 01/23/2026 1140267517 CMS
MIMEDX Group, Inc. $22.86 12/11/2024 Food and Beverage Undisputed 01/23/2026 1140267519 CMS
Novo Nordisk Inc $13.81 02/22/2024 Food and Beverage Undisputed 01/23/2026 1097332556 CMS
Novo Nordisk Inc $121.86 06/13/2024 Food and Beverage Undisputed 01/23/2026 1096705178 CMS
Novo Nordisk Inc $7.01 06/22/2024 Food and Beverage Undisputed 01/23/2026 1096992282 CMS
Novo Nordisk Inc $8.45 08/28/2024 Food and Beverage Undisputed 01/23/2026 1097554363 CMS
Novo Nordisk Inc $14.67 09/26/2024 Food and Beverage Undisputed 01/23/2026 1096875646 CMS
Novo Nordisk Inc $13.44 10/14/2024 Food and Beverage Undisputed 01/23/2026 1096616682 CMS
Novo Nordisk Inc $14.99 10/17/2024 Food and Beverage Undisputed 01/23/2026 1097144796 CMS
Smith+Nephew, Inc. $23.71 09/10/2024 Food and Beverage Undisputed 01/23/2026 1149514743 CMS
Tactile Systems Technology Inc $22.85 02/06/2024 Food and Beverage Undisputed 01/23/2026 1082375981 CMS
Urgo Medical North America, LLC $19.52 11/18/2024 Food and Beverage Undisputed 01/23/2026 1149428325 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.